Anti-inflammatory Synergy from the Sea
Seanergy is a pharmaceutical company developing new a new category of topical therapeutics for the treatment of inflammatory and conditions of the skin, based on the discovery of a synergistic mechanism between anti-inflammatory APIs and Sulphated Polysaccharides extracted from algae.
SPS/Algae – Sulphated Polysaccharides (SPS),
secreted by mono-cellular algae, have been broadly used in pharmaceuticals and cosmetics as inactive ingredients. Seanergy discovered their unique interaction with anti-inflammatory APIs which it at the core of our innovation and proprietary IP.
We are focused exploring the potential of SPS
and delivering it to patients.
Synergy – The combination of SPS with known anti-inflammatory active pharmaceutical ingredients (APIs) is generating a surprisingly potent therapeutic effect. Ex-vivo and in-vivo we are seeing a dramatic improvement across a variety of clinical and histological parameters. We are now taking this discovery to the clinic with an aim to improve patients lives with enhancing potency and eliminating side effects.
Topical inflammations – Seanergy’s innovative topical therapeutics will touch the lives of many millions. Patients suffering from dermatological and auto-immune diseases including Atopic Dermatitis, Psoriasis, Alopecia Areata, Lichen Planus, Seborrhea and numerous other inflammatory skin conditions will be able to receive better, safer and quicker relief.
Technology
The discovery of the synergistic activity of SPS with anti-inflammatory agents has opened the door to a variety of applications. Our first line of technologies is translating synergistic combinations into topical therapeutics for inflammatory conditions of the skin in dermatological, autoimmune, other diseases.
Seanergy’s lead candidates have already demonstrated superior efficacy and better safety across a broad range of parameters in the per-clinical stages of our work. We have seen the effect of the synergistic mechanism in the clinical manifestation of the symptoms, in the histological analysis of the treated tissues, and in key systemic parameters.
Seanergy was born in the unique framework of Mii Fund and Labs. The company is managed and operated by the founders together with the Mii team at the Mii Labs R&D center in Rehovot, near the Weizmann Institute of Science. This structure has allowed the company access to resources far beyond the reach of the usual startup company.
Seanergy was born in the unique framework of Mii Fund and Labs. The company is managed and operated by the founders together with the Mii team at the Mii Labs R&D center in Rehovot, near the Weizmann Institute of Science. This structure has allowed the company access to resources far beyond the reach of the usual startup company.
Mild to moderate Atopic Dermatitis
Psoriasis and Severe Atopic Dermatitis
Undisclosed
